Status epilepticus
What it is
Status epilepticus is a neurological emergency. It is seizures lasting more than 5 minutes, or two back to back seizures without regain of consciousness in between; the same is put as 5 or more minutes of either continuous seizure activity or repetitive seizures without regaining consciousness.
How it presents
Two described cases both meet this. In the first, a witnessed generalized tonic clonic seizure lasts more than 5 minutes, with symmetric tonic clonic movements, uprolling of the eyes, bloody frothing and bladder incontinence. In the second, a seizure lasts less than 1 minute and is followed by another exact event lasting 1.5 minutes, with no regaining of consciousness between the 2 events.
Causes and risk
The causes listed are prolonged febrile seizure, new onset epilepsy, drug intoxication, drug withdrawal, hypoglycemia, electrolyte imbalance, infection, acute head trauma, hypoxia, metabolic disorders, intracranial hemorrhage and ischemic stroke. Where the most common cause is asked among infection such as encephalitis, non-compliance of anti-epileptic drugs, alcohol withdrawal, hypoglycemia and acute traumatic brain injury, the answer marked is non-compliance of anti-epileptic drugs: a tick in red stands beside it, and a red question mark beside the tick.
How it is treated
Treatment runs in timed phases.
- 0 to 5 minutes, stabilization phase. Stabilize the patient: airway, breathing, circulation, disability with a neurologic exam. Time the seizure from its onset and monitor vital signs. Assess oxygenation, give oxygen via nasal cannula or mask, and consider intubation if respiratory assistance is needed. Initiate ECG monitoring. Collect finger stick blood glucose: if glucose is under 60 mg/dl, adults are given 100 mg thiamine IV then 50 ml D50W IV, children of 2 years and over 2 ml/kg D25W IV, and children under 2 years 4 ml/kg D12.5W IV. Attempt IV access and collect electrolytes, hematology, a toxicology screen and, where appropriate, anticonvulsant drug levels.
- 5 to 20 minutes, initial therapy phase. A benzodiazepine is the initial therapy of choice, one of 3 equivalent first line options: intramuscular midazolam, 10 mg above 40 kg and 5 mg for 13 to 40 kg, single dose; intravenous lorazepam, 0.1 mg/kg/dose, max 4 mg/dose, may repeat once; or intravenous diazepam, 0.15 to 0.2 mg/kg/dose, max 10 mg/dose, may repeat once. If none of the three is available, the alternatives are intravenous phenobarbital 15 mg/kg/dose single dose, rectal diazepam 0.2 to 0.5 mg/kg, max 20 mg/dose, or intranasal or buccal midazolam.
- 20 to 40 minutes, second therapy phase. There is no evidence based preferred second therapy. Give one single dose of intravenous fosphenytoin 20 mg PE/kg, max 1500 mg PE/dose, or intravenous valproic acid 40 mg/kg, max 3000 mg/dose, or intravenous levetiracetam 60 mg/kg, max 4500 mg/dose. If none is available, intravenous phenobarbital 15 mg/kg.
- 40 to 60 minutes, third therapy phase. There is no clear evidence to guide therapy in this phase; the choices are to repeat the second line therapy or anesthetic doses of thiopental, midazolam, pentobarbital or propofol, all with continuous EEG monitoring.
Alongside the drugs the emergency room work is the same ABC: maintain the airway and keep it clear of secretions; breathing, with oxygen inhalation and assisted ventilation; circulation, with IV fluids. Give glucose if blood glucose is under 3 mmol per litre, obtain IV access, send laboratory tests, and take a CSF sample to rule out CNS infections. A second page lays the same ladder out in three lines without the clock, and its second line is wider than the timed table. First line is the benzodiazepines: lorazepam (0.1mg/kg), diazepam (0.2mg/kg) and midazolam (0.2 mg/kg). Second line is phenytoin (20mg/kg), fosphenytoin (20mg/kg), valproate (20mg/kg), levetiracetam and lacosamide. Third line is propofol, midazolam, pentobarbital and ketamine. On that page levetiracetam and lacosamide are marked together by hand, in red, for pregnant. Intravenous phenytoin is named in the second line here, beside fosphenytoin, each at 20 mg/kg, and the timed table names fosphenytoin without phenytoin, at 20 mg PE/kg. Neither page rules the other out, so intravenous phenytoin is a second line drug, and lacosamide and ketamine appear only on this page. The same two pages also give valproate two doses for that one second line slot: 20 mg/kg in the three line list, and 40 mg/kg, max 3000 mg/dose, in the timed table. Neither rules the other out either.